← Back to patent-cliff list
CAS 57595-25-2
2,5-dihydrofuran-3,4-dicarboxylic acid
Codes: VIDOCa-001
Application context (from source-drug indications)
Relapsing-remitting multiple sclerosisVidofludimus calciumMultiple sclerosisVidofludimus calciumCOVID-19Vidofludimus calciumUlcerative colitisVidofludimus calciumSclerosing cholangitisVidofludimus calcium
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Vidofludimus calcium | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2,5-dihydrofuran-3,4-dicarboxylic acid→3-fluoro-3'-methoxy-[1,1'-biphenyl]-4-amine→2-((3-fluoro-3'-methoxy-[1,1'-biphenyl]-4-yl)carbamoyl)cyclopent-1-enecarboxylic acid→Vidofludimus Calcium
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.